Monthly News Roundup - March 2024
Rezdiffra Approved as First Drug for Nonalcoholic Fatty Liver Disease (NASH)
In March, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Rezdiffra (resmetirom) for adults with noncirrhotic nonalcoholic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2024 Category: Pharmaceuticals Source Type: news
Aspirin Shows Promise In Treating Common Liver Disease
Daily low dose aspirin may be an effective treatment for a common type of liver disease, according to a new study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 28, 2024 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
FDA approves first drug for NASH — a severe form of fatty liver disease
A Yale Medicine expert discusses Rezdiffra, a new treatment for a serious subtype of fatty liver disease that is not caused by heavy alcohol use. (Source: Yale Science and Health News)
Source: Yale Science and Health News - March 25, 2024 Category: Universities & Medical Training Source Type: news
VCTE-Based Agile Scores Accurate in Predicting Liver-Related Events in MASLD
(MedPage Today) -- The use of Agile scores based on vibration-controlled transient elastography (VCTE) accurately predicted liver-related events in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a cohort... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 25, 2024 Category: Gastroenterology Source Type: news
Weight-loss drugs will not be the only blockbusters against this silent killer
Madrigal is the first to win approval for a treatment for a liver disease that affects one in 20 (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 25, 2024 Category: Pharmaceuticals Source Type: news
Bizarre symptom that ended up being a sign I had an incurable liver disease: Woman, 29, reveals she had a constant itch - which felt 'like ants on your skin' - before devastating diagnosis
Flo Moffat-Charles, 29, from Cumbria, started suffering from extreme fatigue, nausea and chronic itchiness on her hands and feet, months after her wedding. (Source: the Mail online | Health)
Source: the Mail online | Health - March 21, 2024 Category: Consumer Health News Source Type: news
Aspirin Cuts Liver Fat in Preliminary MASLD Trial
(MedPage Today) -- Daily low-dose aspirin reduced hepatic fat in patients with noncirrhotic metabolic dysfunction-associated steatotic liver disease (MASLD), a randomized phase II trial showed.
Among the 80 patients in the single-center study... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 20, 2024 Category: Primary Care Source Type: news
Ultrasound model predicts liver disease progress
A predictive model combining multiple ultrasonic parameters could discriminate between different liver diseases in a study published March 19 in Radiology.
A team of researchers led by Fangyi Liu, MD, from the Chinese PLA General Hospital in Beijing, found that their multiparametric ultrasound model can predict metabolic dysfunction-associated steatohepatitis (MASH) in patients with metabolic dysfunction-associated fatty liver disease (MAFLD), regardless of hepatitis B virus infection status.
“These findings are important for noninvasive assessment of the MAFLD disease process,” the Liu team wrote.
Previous studies ...
Source: AuntMinnie.com Headlines - March 20, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Clinical News Ultrasound Genitourinary Radiology Source Type: news
Alcohol-Associated Cirrhosis and Death Are on the Rise: Here's How We Can Help
(MedPage Today) -- Few Americans, including some healthcare professionals, realize that chronic liver disease is now the 9th leading cause of death in the U.S. Even worse, it is the 5th leading cause of death among adults ages 25 to 64 years old... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 18, 2024 Category: Psychiatry Source Type: news
GLP-1 RA Reduces Severity of Steatotic Liver Disease in People With HIV
MONDAY, March 18, 2024 -- For people with HIV (PWH) with metabolic-associated steatotic liver disease (MASLD), semaglutide is associated with absolute and relative declines in intrahepatic triglyceride (IHTG) content, according to a study presented... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2024 Category: Pharmaceuticals Source Type: news
Mirimus' RNAi Technology Helps Advance New Treatment for Liver Tumors and Acute Chronic Liver Diseases
Leveraging Mirimus RNAi technology, a study led by Tuebingen University shows that a new drug has the potential to revolutionize liver surgery and liver transplantation. NEW YORK, March 18, 2024 /PRNewswire-PRWeb/ -- Mirimus, a pioneer in RNAi therapeutic design and CRISPR/Cas9 gene... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 18, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Madrigal wins first U.S. approval for drug to treat liver disease MASH
The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH. The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals. Metabolic…#rezdiffra #metabolic (Source: Reuters: Health)
Source: Reuters: Health - March 16, 2024 Category: Consumer Health News Source Type: news
FDA Approves First Drug for Common, Serious Liver Disease, Rezdiffra
FRIDAY, March 15, 2024 -- Millions of Americans whose livers develop scar tissue due to a common disease now have the first approved drug, Rezdiffra, to treat the condition, the U.S. Food and Drug Administration announced Thursday.
The condition is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 15, 2024 Category: General Medicine Source Type: news
US FDA approves first drug for fatty liver disease NASH
(Source: Reuters: Health)
Source: Reuters: Health - March 15, 2024 Category: Consumer Health News Source Type: news
Shares of Madrigal Pharmaceuticals soar on FDA approval for NASH treatment
Conshohocken-based Madrigal Pharmaceutical has emerged as the winner in the race to be the first drug company to secure approval for a treatment targeting a liver disease known as NASH. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: John George Source Type: news
